Künstliche Intelligenz in der Krebsforschung und Biomedizin – Artificial Intelligence in Cancer Research and Biomedicine

Artificial Intelligence opens up huge possibilities in a variety of sectors. Imagine that doctor reports can be evaluated mechanically, complex, even unstructured data of hospital information technology can be derived in content specific information.  In regard to the AI approval and publication, an ethical approach is of utmost importance for further development. If we follow the principles of trustworthy ethical AI, then AI will make a decisive contribution to making the lives of many people better. Presentation has been held on October 22nd, 2020 at the Symposium "KI and Krebs - Erkenntnisgewinnung in der Krebsforschung durch künstliche Intelligenz" at Haus der Industrie in Vienna.  AF Institute: https://www.af-institute.at